Guidelines for Stereotactic Radiotherapy in Lung Cancer
Author Information
Author(s): Coen W Hurkmans, Johan P Cuijpers, Frank J Lagerwaard, Joachim Widder, Uulke A van der Heide, Danny Schuring, Suresh Senan
Primary Institution: Catharina Hospital, Eindhoven, The Netherlands
Hypothesis
What are the best practices for implementing stereotactic radiotherapy in patients with operable stage IA lung cancer?
Conclusion
Guidelines were developed to standardize the implementation of stereotactic radiotherapy for lung cancer, which can improve treatment consistency and outcomes.
Supporting Evidence
- Stereotactic radiotherapy improves local control rates compared to conventional treatments.
- The study involved a planning study with 26 patients to develop guidelines.
- Guidelines aim to standardize treatment across multiple centers.
Takeaway
This study created rules to help doctors use a special type of radiation treatment for lung cancer, making sure everyone does it the same way.
Methodology
A Quality Assurance Working Party was formed to develop guidelines based on literature reviews and consensus meetings, along with a planning study involving 26 patients.
Limitations
The guidelines may not cover all technical aspects due to the complexity of stereotactic radiotherapy.
Participant Demographics
Patients with operable stage IA non-small cell lung cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website